MedTrace Logo

A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.

NCT01202604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2011-12-20

No results posted yet for this study

Summary

The primary objective of the study is to evaluate the efficacy of administered maintenance treatments in bipolar disorder I and II, defined as the percentage of patients who experience a relapse episode during the first 9 months after a mood event (manic or depressive).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dr. Panagiotis Pontikis · AstraZeneca S.A. Greece

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01202604 on ClinicalTrials.gov